77T-14114-74229
4 vaccinations
1 coded response
50 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 950 / CA
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-06
Dose 1 — Pfizer-BioNTech
-
2021-04-07
Registered in v-safe
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-11
- 2021-04-12
-
2021-04-13
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Muscle or body achesAdult check-in
- 2021-04-20
-
2021-04-27
Dose 2 — Pfizer-BioNTech
- 2021-04-27
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · None · Be unable to workAdult check-in
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-07-27
- 2021-10-26
-
2021-11-11
Dose 3 — Pfizer-BioNTech
- 2021-11-11
-
2021-11-12
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-16
- 2021-12-23
- 2022-02-10
- 2022-05-12
-
2022-10-11
Dose 4 — Pfizer-BioNTech
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
- 2023-01-10
-
2023-04-12
Survey response — 6 months, dose 4MedDRA: Delivery, Hypertension, Postpartum anxiety, Urinary tract infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-04-12
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2023-04-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Pfizer-BioNTech | |
| 2 | 2021-04-27 | Pfizer-BioNTech | |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
| 4 | 2022-10-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-12 | Successful 2023-04-13 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Postpartum anxiety | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release